Dexmeditomedine Versus No Sedation in Management of Agitation in COPD Patients Receiving Noninvasive Ventilation

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05774145
Collaborator
(none)
80
33.1

Study Details

Study Description

Brief Summary

The aim is to compare sedation using dexmedetomidine to sedation -free approach in management of agitated COPD patients receiving NIV

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The aim is to compare sedation using dexmedetomidine to sedation -free approach in management of agitated COPD patients receiving NIV

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    80 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Dexmeditomedine Versus No Sedation in Management of Agitation in COPD Patients Receiving Noninvasive Ventilation
    Anticipated Study Start Date :
    Mar 1, 2023
    Anticipated Primary Completion Date :
    Dec 1, 2025
    Anticipated Study Completion Date :
    Dec 1, 2025

    Outcome Measures

    Primary Outcome Measures

    1. precedex on COPD irritable on non invasive machine [3/2023_3/2025]

      control of Agitation by RASS

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    Inclusion critera

    • age>18

    • Agitation

    • NIV intolerance Exclusion criteria

    • cardiac dysfunction

    • Hepatic dysfunction

    • Haemodynamic instability

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Assiut University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hoda sultan, Principle investigator, Assiut University
    ClinicalTrials.gov Identifier:
    NCT05774145
    Other Study ID Numbers:
    • Dexmeditomedine Versus No Seda
    First Posted:
    Mar 17, 2023
    Last Update Posted:
    Mar 17, 2023
    Last Verified:
    Mar 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 17, 2023